Involving players with longtime experience in the field, Endsulin is researching the use of gene therapy as a treatment for Type 1 diabetes. The concept and the work underway builds on research that found a single DNA sequence responsible for promoting and activating the human insulin gene. The effort is to produce a single one-time injection which could provide diabetics with better control over their glucose levels and, by extension, improve their health.
